These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26015409)

  • 1. Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.
    Trerotola M; Ganguly KK; Fazli L; Fedele C; Lu H; Dutta A; Liu Q; De Angelis T; Riddell LW; Riobo NA; Gleave ME; Zoubeidi A; Pestell RG; Altieri DC; Languino LR
    Oncotarget; 2015 Jun; 6(16):14318-28. PubMed ID: 26015409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis.
    Trerotola M; Li J; Alberti S; Languino LR
    J Cell Physiol; 2012 Nov; 227(11):3670-7. PubMed ID: 22378065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.
    Trerotola M; Jernigan DL; Liu Q; Siddiqui J; Fatatis A; Languino LR
    Cancer Res; 2013 May; 73(10):3155-67. PubMed ID: 23536555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.
    Guerra E; Trerotola M; Relli V; Lattanzio R; Tripaldi R; Vacca G; Ceci M; Boujnah K; Garbo V; Moschella A; Zappacosta R; Simeone P; de Lange R; Weidle UH; Rotelli MT; Picciariello A; Depalo R; Querzoli P; Pedriali M; Bianchini E; Angelucci D; Pizzicannella G; Di Loreto C; Piantelli M; Antolini L; Sun XF; Altomare DF; Alberti S
    Neoplasia; 2021 Sep; 23(9):898-911. PubMed ID: 34320447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition.
    Remšík J; Binó L; Kahounová Z; Kharaishvili G; Šimecková Š; Fedr R; Kucírková T; Lenárt S; Muresan XM; Slabáková E; Knopfová L; Bouchal J; Král M; Beneš P; Soucek K
    Carcinogenesis; 2018 Dec; 39(11):1411-1418. PubMed ID: 30010814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate.
    Wang X; Qi L; Chen M; Zhang Y; Gao X; Cai Y
    World J Urol; 2024 Jul; 42(1):404. PubMed ID: 38990246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
    Ok Atılgan A; Özdemir BH; Yılmaz Akçay E; Tepeoğlu M; Börcek P; Dirim A
    Ann Diagn Pathol; 2020 Apr; 45():151480. PubMed ID: 32106037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.
    Hu S; Delorme N; Liu Z; Liu T; Velasco-Gonzalez C; Garai J; Pullikuth A; Koochekpour S
    Mol Cancer; 2010 Feb; 9():30. PubMed ID: 20132547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
    Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
    Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.
    Meng F; Joshi B; Nabi IR
    PLoS One; 2015; 10(5):e0126056. PubMed ID: 25942420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.
    Kacsinta AD; Rubenstein CS; Sroka IC; Pawar S; Gard JM; Nagle RB; Cress AE
    Biochem Biophys Res Commun; 2014 Nov; 454(2):335-40. PubMed ID: 25450398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression.
    Zanna P; Trerotola M; Vacca G; Bonasera V; Palombo B; Guerra E; Rossi C; Lattanzio R; Piantelli M; Alberti S
    Cancer; 2007 Jul; 110(2):452-64. PubMed ID: 17559145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
    Wang G; Zhang Z; Ren Y
    Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression.
    Rutka JT; Muller M; Hubbard SL; Forsdike J; Dirks PB; Jung S; Tsugu A; Ivanchuk S; Costello P; Mondal S; Ackerley C; Becker LE
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):198-209. PubMed ID: 10029102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model.
    Slack-Davis JK; Hershey ED; Theodorescu D; Frierson HF; Parsons JT
    Mol Cancer Ther; 2009 Aug; 8(8):2470-7. PubMed ID: 19671741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma.
    Tremblay L; Hauck W; Aprikian AG; Begin LR; Chapdelaine A; Chevalier S
    Int J Cancer; 1996 Oct; 68(2):164-71. PubMed ID: 8900422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions.
    Figel S; Gelman IH
    Anticancer Agents Med Chem; 2011 Sep; 11(7):607-16. PubMed ID: 21355844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation.
    Liu Y; Kyle E; Lieberman R; Crowell J; Kellof G; Bergan RC
    Clin Exp Metastasis; 2000; 18(3):203-12. PubMed ID: 11315093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors.
    Guerra E; Trerotola M; Tripaldi R; Aloisi AL; Simeone P; Sacchetti A; Relli V; D'Amore A; La Sorda R; Lattanzio R; Piantelli M; Alberti S
    Clin Cancer Res; 2016 Aug; 22(16):4197-205. PubMed ID: 27022065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
    Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.